1. Home
  2. CPRX vs MYRG Comparison

CPRX vs MYRG Comparison

Compare CPRX & MYRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CPRX
  • MYRG
  • Stock Information
  • Founded
  • CPRX 2002
  • MYRG 1891
  • Country
  • CPRX United States
  • MYRG United States
  • Employees
  • CPRX N/A
  • MYRG N/A
  • Industry
  • CPRX Biotechnology: Pharmaceutical Preparations
  • MYRG Water Sewer Pipeline Comm & Power Line Construction
  • Sector
  • CPRX Health Care
  • MYRG Industrials
  • Exchange
  • CPRX Nasdaq
  • MYRG Nasdaq
  • Market Cap
  • CPRX 2.6B
  • MYRG 2.3B
  • IPO Year
  • CPRX 2006
  • MYRG N/A
  • Fundamental
  • Price
  • CPRX $24.69
  • MYRG $116.31
  • Analyst Decision
  • CPRX Strong Buy
  • MYRG Strong Buy
  • Analyst Count
  • CPRX 8
  • MYRG 5
  • Target Price
  • CPRX $32.50
  • MYRG $160.80
  • AVG Volume (30 Days)
  • CPRX 1.5M
  • MYRG 331.2K
  • Earning Date
  • CPRX 05-07-2025
  • MYRG 04-30-2025
  • Dividend Yield
  • CPRX N/A
  • MYRG N/A
  • EPS Growth
  • CPRX 107.94
  • MYRG N/A
  • EPS
  • CPRX 1.31
  • MYRG 1.83
  • Revenue
  • CPRX $491,734,000.00
  • MYRG $3,362,290,000.00
  • Revenue This Year
  • CPRX $15.17
  • MYRG $5.08
  • Revenue Next Year
  • CPRX $8.28
  • MYRG $5.94
  • P/E Ratio
  • CPRX $18.96
  • MYRG $63.21
  • Revenue Growth
  • CPRX 23.49
  • MYRG N/A
  • 52 Week Low
  • CPRX $14.47
  • MYRG $86.60
  • 52 Week High
  • CPRX $26.16
  • MYRG $181.02
  • Technical
  • Relative Strength Index (RSI)
  • CPRX 62.78
  • MYRG 41.46
  • Support Level
  • CPRX $20.68
  • MYRG $123.00
  • Resistance Level
  • CPRX $26.16
  • MYRG $130.07
  • Average True Range (ATR)
  • CPRX 0.83
  • MYRG 5.79
  • MACD
  • CPRX 0.36
  • MYRG 0.58
  • Stochastic Oscillator
  • CPRX 75.21
  • MYRG 47.22

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers Firdapse, a proprietary form of amifampridine phosphate for the treatment of patients with Lambert-Eaton myasthenic syndrome.

About MYRG MYR Group Inc.

MYR Group Inc is a U.S.-based holding company that provides specialty electrical construction services through its subsidiaries. The company operates through two segments. The transmission and distribution segment provides designing, engineering, procurement, construction, upgrade, maintenance, and repair services on transmission and distribution network and substation facilities. The commercial and industrial segment provides services such as the design, installation, maintenance, and repair of commercial and industrial wiring, installation of traffic networks, and the installation of bridges. MYR Group generates the majority of its sales from the United States and Canada.

Share on Social Networks: